| 000 | 01783 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517072612.0 | ||
| 264 | 0 | _c20160706 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0146311 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGschwantler-Kaulich, Daphne | |
| 245 | 0 | 0 |
_aHER Specific TKIs Exert Their Antineoplastic Effects on Breast Cancer Cell Lines through the Involvement of STAT5 and JNK. _h[electronic resource] |
| 260 |
_bPloS one _c2016 |
||
| 300 |
_ae0146311 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAfatinib |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aJNK Mitogen-Activated Protein Kinases _xmetabolism |
| 650 | 0 | 4 | _aLapatinib |
| 650 | 0 | 4 | _aMAP Kinase Signaling System |
| 650 | 0 | 4 |
_aMorpholines _xpharmacology |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aProtein Processing, Post-Translational |
| 650 | 0 | 4 |
_aQuinazolines _xpharmacology |
| 650 | 0 | 4 |
_aSTAT5 Transcription Factor _xmetabolism |
| 700 | 1 | _aGrunt, Thomas W | |
| 700 | 1 | _aMuhr, Daniela | |
| 700 | 1 | _aWagner, Renate | |
| 700 | 1 | _aKölbl, Heinz | |
| 700 | 1 | _aSinger, Christian F | |
| 773 | 0 |
_tPloS one _gvol. 11 _gno. 1 _gp. e0146311 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0146311 _zAvailable from publisher's website |
| 999 |
_c25603397 _d25603397 |
||